The Bladder Tumor Microenvironment Components That Modulate the Tumor and Impact Therapy.

Area of Science:

• Oncology
• Cancer Biology
• Immunology

Background:

• The tumor microenvironment (TME) is a complex ecosystem of various cell types that promote cancer progression and therapeutic resistance.
• Single-cell sequencing technologies have significantly advanced our understanding of cellular heterogeneity within the TME.
• Clinical observations suggest that drugs affecting the TME can influence cancer development and treatment outcomes.

Purpose of the Study:

• To review the diverse cell types within the bladder tumor microenvironment.
• To discuss the impact of these cells on immune responses and TME modulation.
• To explore the effects of antihypertensive drugs and anesthetics on bladder cancer within the TME context.

Main Methods:

• Literature review of studies on bladder tumor microenvironment composition and function.
• Analysis of single-cell sequencing data to identify cell types and their interactions.
• Examination of clinical data and pharmacological studies on drug effects within the TME.

Main Results:

• Identified key cell types in the bladder TME including cancer cells, cancer stem cells, endothelial cells, pericytes, adipose cells, cancer-associated fibroblasts, and neuronal cells.
• Detailed the roles of these cells in immune evasion and therapy resistance.
• Summarized evidence on how antihypertensive drugs and anesthetics can modulate the bladder TME and impact cancer progression.

Conclusions:

• The bladder tumor microenvironment is a critical determinant of cancer progression and treatment response.
• Targeting cellular interactions within the TME offers potential therapeutic strategies.
• Further research into drug-mediated TME modulation is warranted for optimizing bladder cancer therapy.